Benzatropine: Difference between revisions
Gerald Chi (talk | contribs) m Changed protection level for "Benzatropine" ([Edit=Allow only autoconfirmed users] (indefinite) [Move=Allow only autoconfirmed users] (indefinite)) |
No edit summary |
||
Line 50: | Line 50: | ||
Other studies have found no association between anticholinergic exposure and risk of developing tardive dyskinesia.<ref name="pmid9546009">{{cite journal |author=van Harten PN, Hoek HW, Matroos GE, Koeter M, Kahn RS |title=Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III |journal=The American journal of psychiatry |volume=155 |issue=4 |pages=565-7 |year=1998 |pmid=9546009 |doi=}}</ref> | Other studies have found no association between anticholinergic exposure and risk of developing tardive dyskinesia.<ref name="pmid9546009">{{cite journal |author=van Harten PN, Hoek HW, Matroos GE, Koeter M, Kahn RS |title=Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III |journal=The American journal of psychiatry |volume=155 |issue=4 |pages=565-7 |year=1998 |pmid=9546009 |doi=}}</ref> | ||
==Pill Images== | |||
{{TempDrugImages}} | |||
{{PillImage|fileName=Benztropine_Mesylate_NDC_06032433.jpg|drugName=Benztropine Mesylate|NDC=06032433|drugAuthor=Qualitest Pharmaceuticals|ingredients=BENZTROPINE MESYLATE[BENZTROPINE]|pillImprint=2325;V|dosageValue=0.5|dosageUnit=mg|pillColor=White|pillShape=Round|pillSize=6|pillScore=2}} | |||
{{PillImage|fileName=Benztropine_Mesylate_NDC_06032434.jpg|drugName=Benztropine Mesylate|NDC=06032434|drugAuthor=Qualitest Pharmaceuticals|ingredients=BENZTROPINE MESYLATE[BENZTROPINE]|pillImprint=2326;V|dosageValue=1|dosageUnit=mg|pillColor=White|pillShape=Oval|pillSize=10|pillScore=2}} | |||
{{PillImage|fileName=Benztropine_Mesylate_NDC_06032435.jpg|drugName=Benztropine Mesylate|NDC=06032435|drugAuthor=Qualitest Pharmaceuticals|ingredients=BENZTROPINE MESYLATE[BENZTROPINE]|pillImprint=2327;V|dosageValue=2|dosageUnit=mg|pillColor=White|pillShape=Round|pillSize=7|pillScore=2}} | |||
{{PillImage|fileName=Benztropine_Mesylate_NDC_08321082.jpg|drugName=Benztropine Mesylate|NDC=08321082|drugAuthor=Upsher-Smith Laboratories, Inc.|ingredients=benztropine mesylate[benztropine]|pillImprint=832;BM2|dosageValue=2|dosageUnit=mg|pillColor=White|pillShape=Round|pillSize=7|pillScore=2}} | |||
{{PillImage|fileName=BENZTROPINE_MESYLATE_NDC_09041055.jpg|drugName=BENZTROPINE MESYLATE|NDC=09041055|drugAuthor=Major Pharmaceuticals|ingredients=BENZTROPINE MESYLATE[BENZTROPINE]|pillImprint=cor;143|dosageValue=0.5|dosageUnit=mg|pillColor=White|pillShape=Round|pillSize=6|pillScore=2}} | |||
{{PillImage|fileName=BENZTROPINE_MESYLATE_NDC_09041056.jpg|drugName=BENZTROPINE MESYLATE|NDC=09041056|drugAuthor=Major Pharmaceuticals|ingredients=BENZTROPINE MESYLATE[BENZTROPINE]|pillImprint=cor;144|dosageValue=1|dosageUnit=mg|pillColor=White|pillShape=Oval|pillSize=8|pillScore=2}} | |||
{{PillImage|fileName=BENZTROPINE_MESYLATE_NDC_09041057.jpg|drugName=BENZTROPINE MESYLATE|NDC=09041057|drugAuthor=Major Pharmaceuticals|ingredients=BENZTROPINE MESYLATE[BENZTROPINE]|pillImprint=cor;145|dosageValue=2|dosageUnit=mg|pillColor=White|pillShape=Round|pillSize=8|pillScore=2}} | |||
{{PillImage|fileName=Benztropine_Mesylate_NDC_501110395.jpg|drugName=Benztropine Mesylate|NDC=501110395|drugAuthor=Pliva Inc.|ingredients=BENZTROPINE MESYLATE[BENZTROPINE]|pillImprint=b;1116|dosageValue=2|dosageUnit=mg|pillColor=White|pillShape=Round|pillSize=6|pillScore=2}} | |||
{{PillImage|fileName=Benztropine_Mesylate_NDC_08321080.jpg|drugName=Benztropine Mesylate|NDC=08321080|drugAuthor=Upsher-Smith Laboratories, Inc.|ingredients=benztropine mesylate[benztropine]|pillImprint=832;BM05|dosageValue=0.5|dosageUnit=mg|pillColor=White|pillShape=Round|pillSize=6|pillScore=2}} | |||
{{PillImage|fileName=Benztropine_Mesylate_NDC_08321081.jpg|drugName=Benztropine Mesylate|NDC=08321081|drugAuthor=Upsher-Smith Laboratories, Inc.|ingredients=benztropine mesylate[benztropine]|pillImprint=832;BM1|dosageValue=1|dosageUnit=mg|pillColor=White|pillShape=Oval|pillSize=11|pillScore=2}} | |||
{{PillImage|fileName=Benztropine_Mesylate_NDC_501110393.jpg|drugName=Benztropine Mesylate|NDC=501110393|drugAuthor=Pliva Inc.|ingredients=BENZTROPINE MESYLATE[BENZTROPINE]|pillImprint=b;1114|dosageValue=0.5|dosageUnit=mg|pillColor=White|pillShape=Round|pillSize=6|pillScore=2}} | |||
{{PillImage|fileName=BENZTROPINE_MESYLATE_NDC_649800111.jpg|drugName=BENZTROPINE MESYLATE|NDC=649800111|drugAuthor=Rising Pharmaceuticals Inc|ingredients=BENZTROPINE MESYLATE[BENZTROPINE]|pillImprint=cor;143|dosageValue=0.5|dosageUnit=mg|pillColor=White|pillShape=Round|pillSize=6|pillScore=2}} | |||
{{PillImage|fileName=BENZTROPINE_MESYLATE_NDC_649800112.jpg|drugName=BENZTROPINE MESYLATE|NDC=649800112|drugAuthor=Rising Pharmaceuticals Inc|ingredients=BENZTROPINE MESYLATE [BENZTROPINE]|pillImprint=cor;144|dosageValue=1|dosageUnit=mg|pillColor=White|pillShape=Oval|pillSize=8|pillScore=2}} | |||
==References== | ==References== |
Revision as of 22:28, 16 July 2014
Error creating thumbnail: File missing | |
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | oral, IM, IV |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 36 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C21H25NO |
Molar mass | 307.429 g/mol |
WikiDoc Resources for Benzatropine |
Articles |
---|
Most recent articles on Benzatropine Most cited articles on Benzatropine |
Media |
Powerpoint slides on Benzatropine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Benzatropine at Clinical Trials.gov Clinical Trials on Benzatropine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Benzatropine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Benzatropine Discussion groups on Benzatropine Patient Handouts on Benzatropine Directions to Hospitals Treating Benzatropine Risk calculators and risk factors for Benzatropine
|
Healthcare Provider Resources |
Causes & Risk Factors for Benzatropine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Benzatropine mesilate (INN, commonly known as benztropine; marketed as Cogentin) is an anticholinergic drug principally used for the treatment of:
- Drug-induced parkinsonism, akathisia and acute dystonia;
- Parkinson disease; and
- Idiopathic or secondary dystonia.
Indications
It is used in patients with schizophrenia to reduce the side effects of antipsychotic treatment, such as parkinsonism and akathisia.
Benztropine is also a second-line drug for the treatment of Parkinson's disease. It improves tremor but not rigidity or bradykinesia.
Benztropine is also sometimes used for the treatment of dystonia, a rare disorder that causes abnormal muscle contraction, resulting in twisting postures of limbs, trunk, or face.
Side effects
These are principally anticholinergic:
- Dry mouth
- Blurred vision
- Cognitive changes
- Constipation
- Urinary retention
- Tachycardia
- Anorexia
- Psychosis (usually in overdose)
Some studies suggest that use of anticholinergics increases the risk of tardive dyskinesia, a long-term side effect of antipsychotics.[1][2]
Other studies have found no association between anticholinergic exposure and risk of developing tardive dyskinesia.[3]
Pill Images
{{#ask: Page Name::Benzatropine |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }} {{#subobject:
|Page Name=Benzatropine |Pill Name=Benztropine_Mesylate_NDC_06032433.jpg |Drug Name=Benztropine Mesylate |Pill Ingred=BENZTROPINE MESYLATE[BENZTROPINE]|+sep=; |Pill Imprint=2325;V |Pill Dosage=0.5 mg |Pill Color=White|+sep=; |Pill Shape=Round |Pill Size (mm)=6 |Pill Scoring=2 |Pill Image= |Drug Author=Qualitest Pharmaceuticals |NDC=06032433
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=Benztropine_Mesylate_NDC_06032434.jpg |Drug Name=Benztropine Mesylate |Pill Ingred=BENZTROPINE MESYLATE[BENZTROPINE]|+sep=; |Pill Imprint=2326;V |Pill Dosage=1 mg |Pill Color=White|+sep=; |Pill Shape=Oval |Pill Size (mm)=10 |Pill Scoring=2 |Pill Image= |Drug Author=Qualitest Pharmaceuticals |NDC=06032434
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=Benztropine_Mesylate_NDC_06032435.jpg |Drug Name=Benztropine Mesylate |Pill Ingred=BENZTROPINE MESYLATE[BENZTROPINE]|+sep=; |Pill Imprint=2327;V |Pill Dosage=2 mg |Pill Color=White|+sep=; |Pill Shape=Round |Pill Size (mm)=7 |Pill Scoring=2 |Pill Image= |Drug Author=Qualitest Pharmaceuticals |NDC=06032435
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=Benztropine_Mesylate_NDC_08321082.jpg |Drug Name=Benztropine Mesylate |Pill Ingred=benztropine mesylate[benztropine]|+sep=; |Pill Imprint=832;BM2 |Pill Dosage=2 mg |Pill Color=White|+sep=; |Pill Shape=Round |Pill Size (mm)=7 |Pill Scoring=2 |Pill Image= |Drug Author=Upsher-Smith Laboratories, Inc. |NDC=08321082
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=BENZTROPINE_MESYLATE_NDC_09041055.jpg |Drug Name=BENZTROPINE MESYLATE |Pill Ingred=BENZTROPINE MESYLATE[BENZTROPINE]|+sep=; |Pill Imprint=cor;143 |Pill Dosage=0.5 mg |Pill Color=White|+sep=; |Pill Shape=Round |Pill Size (mm)=6 |Pill Scoring=2 |Pill Image= |Drug Author=Major Pharmaceuticals |NDC=09041055
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=BENZTROPINE_MESYLATE_NDC_09041056.jpg |Drug Name=BENZTROPINE MESYLATE |Pill Ingred=BENZTROPINE MESYLATE[BENZTROPINE]|+sep=; |Pill Imprint=cor;144 |Pill Dosage=1 mg |Pill Color=White|+sep=; |Pill Shape=Oval |Pill Size (mm)=8 |Pill Scoring=2 |Pill Image= |Drug Author=Major Pharmaceuticals |NDC=09041056
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=BENZTROPINE_MESYLATE_NDC_09041057.jpg |Drug Name=BENZTROPINE MESYLATE |Pill Ingred=BENZTROPINE MESYLATE[BENZTROPINE]|+sep=; |Pill Imprint=cor;145 |Pill Dosage=2 mg |Pill Color=White|+sep=; |Pill Shape=Round |Pill Size (mm)=8 |Pill Scoring=2 |Pill Image= |Drug Author=Major Pharmaceuticals |NDC=09041057
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=Benztropine_Mesylate_NDC_501110395.jpg |Drug Name=Benztropine Mesylate |Pill Ingred=BENZTROPINE MESYLATE[BENZTROPINE]|+sep=; |Pill Imprint=b;1116 |Pill Dosage=2 mg |Pill Color=White|+sep=; |Pill Shape=Round |Pill Size (mm)=6 |Pill Scoring=2 |Pill Image= |Drug Author=Pliva Inc. |NDC=501110395
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=Benztropine_Mesylate_NDC_08321080.jpg |Drug Name=Benztropine Mesylate |Pill Ingred=benztropine mesylate[benztropine]|+sep=; |Pill Imprint=832;BM05 |Pill Dosage=0.5 mg |Pill Color=White|+sep=; |Pill Shape=Round |Pill Size (mm)=6 |Pill Scoring=2 |Pill Image= |Drug Author=Upsher-Smith Laboratories, Inc. |NDC=08321080
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=Benztropine_Mesylate_NDC_08321081.jpg |Drug Name=Benztropine Mesylate |Pill Ingred=benztropine mesylate[benztropine]|+sep=; |Pill Imprint=832;BM1 |Pill Dosage=1 mg |Pill Color=White|+sep=; |Pill Shape=Oval |Pill Size (mm)=11 |Pill Scoring=2 |Pill Image= |Drug Author=Upsher-Smith Laboratories, Inc. |NDC=08321081
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=Benztropine_Mesylate_NDC_501110393.jpg |Drug Name=Benztropine Mesylate |Pill Ingred=BENZTROPINE MESYLATE[BENZTROPINE]|+sep=; |Pill Imprint=b;1114 |Pill Dosage=0.5 mg |Pill Color=White|+sep=; |Pill Shape=Round |Pill Size (mm)=6 |Pill Scoring=2 |Pill Image= |Drug Author=Pliva Inc. |NDC=501110393
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=BENZTROPINE_MESYLATE_NDC_649800111.jpg |Drug Name=BENZTROPINE MESYLATE |Pill Ingred=BENZTROPINE MESYLATE[BENZTROPINE]|+sep=; |Pill Imprint=cor;143 |Pill Dosage=0.5 mg |Pill Color=White|+sep=; |Pill Shape=Round |Pill Size (mm)=6 |Pill Scoring=2 |Pill Image= |Drug Author=Rising Pharmaceuticals Inc |NDC=649800111
}}
{{#subobject:
|Page Name=Benzatropine |Pill Name=BENZTROPINE_MESYLATE_NDC_649800112.jpg |Drug Name=BENZTROPINE MESYLATE |Pill Ingred=BENZTROPINE MESYLATE [BENZTROPINE]|+sep=; |Pill Imprint=cor;144 |Pill Dosage=1 mg |Pill Color=White|+sep=; |Pill Shape=Oval |Pill Size (mm)=8 |Pill Scoring=2 |Pill Image= |Drug Author=Rising Pharmaceuticals Inc |NDC=649800112
}}
References
- ↑ "Arch Gen Psychiatry -- Abstract: Tardive dyskinesia: prevalence and risk factors, 1959 to 1979, April 1982, Kane and Smith 39 (4): 473". Retrieved 2007-08-14.
- ↑ Wszola BA, Newell KM, Sprague RL (2001). "Risk factors for tardive dyskinesia in a large population of youths and adults". Experimental and clinical psychopharmacology. 9 (3): 285–96. PMID 11534539.
- ↑ van Harten PN, Hoek HW, Matroos GE, Koeter M, Kahn RS (1998). "Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III". The American journal of psychiatry. 155 (4): 565–7. PMID 9546009.
- Pages with script errors
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs
- Anticholinergics
- Dopamine reuptake inhibitors
- Muscarinic antagonists
- Tardive dyskinesia